FLOWAY PIPE SERVICES LIMITED

Company number 01244739 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: C-

Explanation: Floway Pipe Services Limited is not in immediate critical care—its liabilities are very low and it possesses positive net assets. However, it is suffering from chronic cash anemia and muscle atrophy (shrinking asset base). The business has seen a steady decline in its overall financial mass since 2020, and its cash reserves have nearly flatlined, which severely restricts its ability to respond to financial shocks or fund day-to-day operations without external support.


Key Vital Signs

  • Cash Reserves (Oxygen Supply): £964 This is the most alarming vital sign. Cash has plummeted from £190,303 in 2020 and £74,544 in 2023 to under £1,000. A business cannot survive long without oxygen; this indicates severe constraints on working capital.
  • Net Assets (Body Mass): £169,441 While still positive, the company's net assets have been steadily shrinking from a peak of £447,826 in 2020. This represents a significant loss of financial mass over a four-year period.
  • Current Ratio (Blood Pressure): 7.56 Calculated as Current Assets (£42,886) divided by Current Liabilities (£5,670). On the surface, this looks incredibly healthy, suggesting the company can easily cover its short-term debts. However, this is a false positive—almost all of the "blood" is trapped in debtors (money owed by customers), not in the cash flow.
  • Profitability (Metabolism): Declining The Profit and Loss reserve dropped from £137,920 to £128,777, indicating that the company operated at a loss of roughly £9,143 during the year (assuming no dividends were paid). The business is burning through its own reserves to sustain itself.
  • Asset Base (Muscle Tone): Significant Contraction The company disposed of £126,223 worth of gross assets during the year, completely divesting itself of Plant & Machinery, Motor Vehicles, and Fixtures & Fittings. It now relies almost entirely on Freehold Land & Property.

Diagnosis

The patient is suffering from chronic cash anemia and acute muscle atrophy.

While the balance sheet shows no toxic levels of debt (only £5,670 in current liabilities), the underlying health of the business is frail. The company has systematically shed its operational assets over the past few years, culminating in a major disposal of equipment in the latest financial year. This suggests the business has either entirely ceased active trading operations, is now subcontracting all physical work, or is in a slow wind-down phase.

The most immediate symptom of distress is the cash position. With less than £1,000 in the bank, the company is relying entirely on the timely payment of its £41,922 trade debtors to keep the lights on. If those debtors delay payment, the business will require an immediate cash transfusion (likely from the directors) to survive. The steady erosion of net assets since 2020 confirms that the business model, as previously constituted, has been loss-making.


Recommendations

  1. Improve Cash Circulation (Debt Collection): With only £964 in cash, collecting the £33,678 owed by trade debtors is an absolute emergency. Implement rigorous credit control procedures to accelerate payment and convert those receivables into life-sustaining cash.
  2. Assess the Operational Model: The disposal of all physical operating assets is a drastic surgical procedure. Directors must confirm whether the company is now acting purely as a labor broker/subcontractor, or if it is preparing for dissolution. If still trading, the business must ensure its pricing model covers the new cost structure (e.g., hiring equipment rather than owning it).
  3. Stop the Metabolic Bleeding: The company is operating at a loss. Conduct an immediate review of overheads and pricing to ensure that every job contributes positively to the P&L reserve.
  4. Emergency Cash Transfusion: Until trade debtors are collected, the directors may need to inject a short-term loan into the business to cover immediate overheads and prevent insolvency due to pure cash flow starvation.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 26 August 2026